doi: 10.3389/fphar.2024.1508696 Received 10 October 2024 Accepted 23 December 2024 Published 15 January 2025 Volume 15 - 2024 Edited by Raul Chavez-Valdez, Johns Hopkins Medicine, United States Reviewed by Eric S
Disclaimer These statements have not been evaluated by the Food and Drug Administration
For some research subjects, a dose of 250mcg two or three times a week might be sufficient
However, its important to use them cautiously if youre experiencing gastrointestinal side effects from Mounjaro like nausea or constipation
We noted, in the CY 2026 OPPS/ASC proposed rule, that based on the description provided by the applicant, that the aprevo Cervical ACDF System is a personalized interbody cage that is implanted using an anterior surgical approach, and therefore, could be appropriately described by C1831
,